DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Futuximab
Futuximab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Deciphering Molecular Mechanisms and Prioritizing Therapeutic Targets in Cardio-Oncology
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
2017 Immuno-Oncology Medicines in Development
Valstybinės Vaistų Kontrolės Tarnybos Prie Lietuvos Respublikos Sveikatos Apsaugos Ministerijos Viršininko Į S a K Y M a S
The Two Tontti Tudiul Lui Hi Ha Unit
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
(INN) for Biological and Biotechnological Substances
Therapeutic Antibody
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
(INN) for Biological and Biotechnological Substances
HER Family Receptor Activation and Dimerisation in Colorectal Cancer and Cancer-Derived Exosomes
Biotherapeutic Antibodies for the Treatment of Head and Neck Cancer
(12) Patent Application Publication (10) Pub. No.: US 2016/0177276 A1 L0 Et Al
CLINICAL TRIAL PROTOCOL Trial Title
Top View
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
One for Treatment of Solid Cancers
International Application Number: PCT/US20 18/064294 (22) International Filing Date: 06 December 2018 (06
The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
Ctdna Applications and Integration in Colorectal Cancer: an NCI Colon and Rectal–Anal Task Forces Whitepaper
Colorectal Cancer: from Genetic Landscape to Targeted Therapy
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
(2006.01) C07d 413/14
2018-Efficacy of Sym004.Pdf
( 12 ) Patent Application Publication
Efficacy of Sym004 in Patients with Metastatic Colorectal Cancer With
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients
(INN) for Biological and Biotechnological Substances
Efficacy of Sym004 in Patients with Metastatic
Plantillaportadatdx RET Con Diposit UB
W O 2017/160990 A1 21 September 2017 (21.09.2017) W I PO I P C T
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al